Evidence map›Paper›PMID 37461001›Full record

Observational studyBMC cardiovascular disorders2023

Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention).

Lijuan Chen, Yuanyuan Zhao, Zheng Wang, Yifei Wang, Xiangwei Bo, Xiaoxi Jiang, Chunshu Hao, Chengwei Ju, Yangyang Qu, Hongjian Dong

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC cardiovascular disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Lijuan ChenDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Yuanyuan ZhaoDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Zheng WangDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Yifei WangDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Xiangwei BoDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Xiaoxi JiangDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Chunshu HaoDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Chengwei JuDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Yangyang QuDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China.
Hongjian DongDepartment of Cardiology, Zhongda Hospital, Southeast University, 210009, Nanjing, China. forestdhj@163.com.
Zhongda Hospital Southeast University · CNSoutheast University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies in populations with or without cardiovascular disease have shown that very high HDL-C levels are associated with an increased risk of cardiovascular events. However, the exact relationship between HDL-C levels and long-term prognosis remains unknown in patients with myocardial infarction (MI) undergoing percutaneous coronary intervention (PCI).

methodsThis was a post hoc secondary analysis of long-term follow-up results in patients undergoing PCI open-label, observational cohort study. Patients with MI who had undergone PCI were enrolled. Restricted cubic spline (RCS) analysis and logistic regression analysis were performed to assess the relationship between HDL-C levels and the risk of cardiovascular events.

resultsA total of 1934 patients with MI undergoing PCI were enrolled in our analysis and our population was divided in 3 groups according to the HDL-C plasma levels: HDL-C < 40 mg/dL (low HDL-C); HDL-C between 40 and 80 mg/ dL (medium HDL-C); and HDL-C > 80 mg/dL (high HDL-C). RCS analysis showed a nonlinear U-shaped association between HDL-C levels and major adverse cardiac and cerebrovascular events (MACCE) in patients with NSTEMI with adjusted variables. After adjusting for potential confounders, the follow-up analysis indicated that high risk group had elevated occurrence of MACCE than low risk group (HDL-C 35 and 55 mg/dL) (OR:1.645, P = 0.006).

conclusionsOur analysis demonstrated that there is a U-shaped association between HDL-C and MACCE in patients with NSTEMI undergoing PCI.

Indexed as

Cardiovascular DiseasesMyocardial InfarctionNon-ST Elevated Myocardial InfarctionPercutaneous Coronary InterventionST Elevation Myocardial InfarctionCholesterol, HDLHeart Disease Risk FactorsHumansRisk FactorsTreatment OutcomeCholesterol, HDLCholesterolDyslipidemiaHigh-density lipoproteinMACCENSTEMIPercutaneous coronary intervention

Identifiers

PMID37461001
PMCPMC10353083
OpenAlexW4384498996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.